(Q40495770)

21 September 2017

1 reference

title

Anti-infective treatment in intensive care: the role of glycopeptides (English)

1 reference

21 September 2017

Grüneberg RN

1

1 reference

21 September 2017

Wilson AP

series ordinal

2

1 reference

21 September 2017

publication date

1 November 1994

1 reference

21 September 2017

published in

Intensive Care Medicine

1 reference

21 September 2017

volume

20 Suppl 4

1 reference

21 September 2017

page(s)

S17-22

1 reference

Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Clinical and Microbiologic Aspects of Serious Infections Caused by Staphylococcus Epidermidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Pharmacokinetics of teicoplanin in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Teicoplanin in infections caused by methicillin-resistant staphylococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Screening and treatment of infections caused by resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

A review of the safety profile of teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01713978

Dosage recommendations for teicoplanin

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function

1 reference

12 December 2020

Enterococcus species in urinary tract infection

1 reference

12 December 2020

Coagulase-negative staphylococcal bacteraemia treated with teicoplanin

1 reference

12 December 2020

Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results

1 reference

12 December 2020

The effect of selective decontamination of the digestive tract on gastrointestinal enterococcal colonization in ITU patients

1 reference

12 December 2020

Teicoplanin vs. vancomycin for the treatment of serious infections: a randomised trial

1 reference

12 December 2020

World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.

1 reference

12 December 2020

Comparison of two methods of bacteriologic sampling of the lower respiratory tract: a study in ventilated patients with nosocomial bronchopneumonia

1 reference

12 December 2020

Vancomycin therapy for infective endocarditis

1 reference

12 December 2020

Pharmacokinetics of teicoplanin in hemodialysis patients

1 reference

12 December 2020

Nosocomial infections in intensive care units

1 reference

12 December 2020

Vancomycin pharmacokinetics in critically ill patients

1 reference

12 December 2020

A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients

1 reference

12 December 2020

Vancomycin Therapy in Patients with Impaired Renal Function: A Nomogram for Dosage

1 reference

12 December 2020

Enterococcus faecium sensitive to teicoplanin but not vancomycin

1 reference

12 December 2020

Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition?

1 reference

12 December 2020

Efficacy and pharmacokinetics of teicoplanin in hemodialysis patients

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics in critically ill patients

1 reference

12 December 2020

Emergence of vancomycin resistance in coagulase-negative staphylococci

1 reference

12 December 2020

Two distinct forms of vancomycin resistance amongst enterococci in the UK.

1 reference

12 December 2020

Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Nosocomial infections

1 reference

12 December 2020

A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies

1 reference

12 December 2020

The bactericidal activity of vancomycin and teicoplanin against methicillin-resistant strains of coagulase negative Staphylococcus spp

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01713978

1 reference

21 September 2017

1 reference